Paul Tudor Jones II acquired 51.3 Thousand Novo Nordisk shares worth $6.91 Million. That's 0.09% of their equity portfolio (307th largest holding). The first Novo Nordisk trade was made in Q4 2021. Since then Paul Tudor Jones II bought shares five more times and sold shares on three occasions. The investor's estimated purchase price is $7.36 Million, resulting in a loss of 6.1%.